The Science2Society Knowledge Database awaits your input

News

FacebookGoogleLinkedInTwitter

23 July, 2018   News

The Science2Society project is allowing external stakeholders to contribute to its Knowledge Database by uploading content for Case Studies, Methods, and Tools that are related to any of the seven schemas defined in the scope of the project.

 

Users willing to contribute must register in the Science2Society website. Once uploaded, the contents will be reviewed by Science2Society project members to ensure adequacy and completeness prior to their publishing. Content published in the Knowledge Database will be publicly available.

The Knowledge Database in one of the building blocks to support the Learning and Implementation Alliance that will undertake the work started by Science2Society after the end of the project.

Registration is now open.

To access the knowledge database and register, visit the S2S website.

About Science2Society:

The Science2Society project is improving the European Innovation system and allowing our societies to receive the beneficial impact of knowledge, through the analysis of new paradigms; such as Open Innovation and Open Science. This is achieved through the in-depth study of seven schemes: Co-Creation, Co-Location, Collaborative R&D Projects, Intersectoral Staff Mobility, Big Research Data Transfer, University Knowledge Transfer and Innovation Marketplace.

S2S is made up of 18 partners, among which are Innoget and major companies such as FCA (Fiat-Chrysler Automobiles), Atos and CA Technologies, and leading European research entities such as KU Leuven, Karlsruhe Institute of Technology, Aalto University and Fraunhofer.

Other News

Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting

  • 17 September, 2020

--- This article was originally published on the press room portal at lilly.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- - Primary endpoint of viral load change from baseline at day 11 was met for one of three doses; consistent effects of viral reduction seen at earlier time points - Rate of hospitalizations and ER visits was 1.7 percent (5/302...

Read more about this

NIH researchers investigate virulence of SARS-CoV-2 virus

  • 25 June, 2020

--- This article was originally published by Samantha Black, PhD, The Science Advisory Board staff writer on the digital media scienceboard.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- What makes the SARS-CoV-2 virus so virulent? Researchers from the U.S. National Institutes of Health (NIH) analyzed the genomics of the virus -- and compar...

Read more about this

Sexton, BioSpherix collaborate to support cell & gene therapy needs

  • 25 June, 2020

--- This article was originally published by The Science Advisory Board staff writers on the digital media scienceboard.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- Sexton Biotechnologies is partnering with BioSpherix Medical on the final steps of downstream bioprocessing, fill-finish. Sexton's off-the-shelf fill system, the Sexton Biot...

Read more about this


Find More News